AR113345A1 - ANTI-TRANSTIRETIN ANTIBODIES - Google Patents
ANTI-TRANSTIRETIN ANTIBODIESInfo
- Publication number
- AR113345A1 AR113345A1 ARP180102878A ARP180102878A AR113345A1 AR 113345 A1 AR113345 A1 AR 113345A1 AR P180102878 A ARP180102878 A AR P180102878A AR P180102878 A ARP180102878 A AR P180102878A AR 113345 A1 AR113345 A1 AR 113345A1
- Authority
- AR
- Argentina
- Prior art keywords
- ttr
- antibodies
- transtiretin
- accumulation
- amyloidosis
- Prior art date
Links
Landscapes
- Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
- Peptides Or Proteins (AREA)
Abstract
La presente provee anticuerpos que se unen específicamente a transtiretina (TTR). Los anticuerpos pueden ser utilizados para tratar o efectuar la profilaxis de enfermedades o trastornos asociados con acumulación de TTR o acumulación de depósitos de TTR (por ej. amiloidosis por TTR). Los anticuerpos también pueden ser utilizados para diagnosticar amiloidosis por TTR e inhibir o reducir la agregación de TTR, y para monitorear la eficacia de terapias contra TTR, entre otras aplicaciones.The present provides antibodies that specifically bind to transthyretin (TTR). The antibodies can be used to treat or effect prophylaxis of diseases or disorders associated with accumulation of TTR or accumulation of TTR deposits (eg, TTR amyloidosis). Antibodies can also be used to diagnose TTR amyloidosis and inhibit or reduce TTR aggregation, and to monitor the efficacy of TTR therapies, among other applications.
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US201762569436P | 2017-10-06 | 2017-10-06 |
Publications (1)
Publication Number | Publication Date |
---|---|
AR113345A1 true AR113345A1 (en) | 2020-04-22 |
Family
ID=70465591
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
ARP180102878A AR113345A1 (en) | 2017-10-06 | 2018-10-05 | ANTI-TRANSTIRETIN ANTIBODIES |
Country Status (1)
Country | Link |
---|---|
AR (1) | AR113345A1 (en) |
-
2018
- 2018-10-05 AR ARP180102878A patent/AR113345A1/en unknown
Similar Documents
Publication | Publication Date | Title |
---|---|---|
CU20200021A7 (en) | ANTI-TRANSTIRETIN ANTIBODIES | |
CO2017008476A2 (en) | Anti-transthyretin antibodies | |
CO2017008482A2 (en) | Anti-transthyretin antibodies | |
CO2017008469A2 (en) | Anti-transthyretin antibodies | |
CL2022001189A1 (en) | Antibodies to cd40. (application divisional n° 2017003427) | |
CU20170052A7 (en) | ANTIBODY MOLECULES THAT JOIN PD-L1 | |
ECSP19044183A (en) | (AZA) INDOL-, BENZOTHIOPHEN, AND BENZOFURAN-3-SULFONAMIDES | |
BR112017024877A2 (en) | anti-cd38 antibody and its use in the treatment of light chain amyloidosis and other cd38 positive haematological malignancies | |
BR112018010464A8 (en) | topical pharmaceutical formulations to treat related inflammatory conditions | |
UY36032A (en) | ANTIBODY MOLECULES THAT JOIN LAG-3 AND USES OF THE SAME | |
WO2018007924A3 (en) | Anti-transthyretin antibodies | |
MX2020003783A (en) | Antibody molecules to cd138 and uses thereof. | |
ZA201906100B (en) | Combination of a ppar agonist with a fxr agonist | |
WO2018007923A3 (en) | Anti-transthyretin antibodies | |
AR113345A1 (en) | ANTI-TRANSTIRETIN ANTIBODIES | |
CL2020000586A1 (en) | Modulators of enac expression. | |
AR103549A1 (en) | ANTI-TRANSTIRETINE ANTIBODIES | |
EA202090898A1 (en) | ANTITRANSTYRETIN ANTIBODIES | |
AR103548A1 (en) | ANTI-TRANSTIRETINE ANTIBODIES | |
CO2021000349A2 (en) | Complement Component 5 Antibody Molecules and Their Uses | |
CR20190329A (en) | MODULATORS OF COMPLEMENT FACTOR Bi |